1. Medtech Insight
  2. >>Geography
  3. >>North America
  4. >>United States

Big Data: Health Care’s Brave New World

Data Analytics Promise To Change How Health Care Products Are Used, Approved, And Reimbursed

Health care is in the midst of a major transformation as data becomes the focal point of vital decisions that will affect patient care and everything used to deliver that care. Just as other industries have found ways to utilize data analytics to turn “Big Data” into a cost savings and efficiency tool, so too is health care moving to embrace the potential of Big Data to both improve patient care and impact the bottom line. For device manufacturers, this shift could bring a fundamental change in the way medical products are assessed, adopted, and reimbursed.

Data has suddenly become the hot topic in health care, as the adoption of health care information technology (HIT) is poised to give hospitals an unprecedented amount of digital patient information. The Health Information Technology for Economic Clinical Health (HITECH) Act of 2009, which, in part, mandated the adoption of electronic health records (EHRs), has been the impetus behind this new era of what is being called “Big Data.” Although a number of hospitals initially had to be forced to embrace the technology, these facilities now realize they are starting to collect a wealth of patient information that could prove very valuable. As this shift gains momentum, observers are beginning to speculate about how the Big Data trend might change a number of established protocols that determine how patients are treated and how new products are approved and adopted.

The initial objective of this effort to pull health care delivery into the realm of 21st-century technology was to improve...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from United States

Increasing Safety Concerns Spur Scrutiny of Device Plastics Use

 
• By Elizabeth Orr

With new regulations limiting the use of plastics popping up worldwide, the medtech industry sees arguments on both sides. Some argue hasty bans of PFAS ("forever chemicals") would harm patients, while others say phthalates should be phased out to protect the public.

With LDT Rule DOA, Could FDA Shift Focus To RUOs?

 
• By Brian Bossetta

Now that the US FDA has chosen not to appeal a March ruling effectively killing the agency’s efforts to regulate lab-developed tests as medical devices, will the agency adopt a different strategy to flex its regulatory muscle?

US FDA Unveils Plans To Consolidate Support Services

 
• By Derrick Gingery and Sue Sutter

Commissioner Martin Makary told staff that plans are being developed to centralize HR, IT, travel and other functions, which were heavily impacted by the 1 April reduction-in-force.

A Year After Exiting The Ventilator Market, Medtronic Recalls Thousands Of Newport Devices

 
• By Brian Bossetta

After two serious injuries and one death linked to some of its ventilators, Medtronic has recalled the devices and asked customers to stop using them and find alternative means. The action comes more than a year after the company left the market.

More from North America

MDUFA VI Launches With Public Meeting, Call For Comments

 
• By Elizabeth Orr

Preparations for the reauthorization of the Medical Device User Fee Amendments for 2028-2032 are underway, with the US FDA announcing a public meeting for 4 August. After negotiations with industry and other stakeholders, a draft agreement is due to Congress by 15 January 2025.

Permanent FDA Top Lawyer Expected After HHS Counsel Confirmation

 
• By Sue Sutter

Robert Foster, HHS deputy general counsel and chief counsel for food, research and drugs, is temporarily heading the Office of Chief Counsel, but a permanent appointee is expected after Michael Stuart's confirmation as HHS general counsel.

FDA Drops Package Labeling Guidance For Hernia Mesh Manufacturers

 
• By Brian Bossetta

The US FDA recently published a draft guidance document for manufacturers of mesh products that are used during several types of hernia repair procedures.